Lv1
40 积分 2021-11-19 加入
Blinatumomab in Combined Immune Thrombocytopenia and Antiphospholipid Syndrome
8天前
已完结
Obstetric antiphospholipid syndrome: Advances in pathogenesis
11天前
已关闭
Criterion validity of the EULAR Antiphospholipid Syndrome Disease Activity Score (EAPSDAS)
11天前
已关闭
Inducibility or predestination? Queries and concepts around drug-free remission in rheumatoid arthritis
1个月前
已完结
Promise of rheumatoid arthritis therapy: From clinical deep remission to drug-free remission
1个月前
已完结
Current status of cardiovascular risk factor control in antiphospholipid syndrome: where are we now?
2个月前
已关闭
The increase of monocyte/high-density lipoprotein cholesterol ratio precedes recurrent thrombosis in patients with APS
2个月前
已关闭
Survival, comorbidities and joint damage 11 years after the COBRA combination therapy trial in early rheumatoid arthritis
2个月前
已完结
COBRA combination therapy in patients with early rheumatoid arthritis: Long‐term structural benefits of a brief intervention
2个月前
已完结
RA remission maintained after MTX withdrawal
2个月前
已完结
皖公网安备34019202002308
